vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and PURE CYCLE CORP (PCYO). Click either name above to swap in a different company.

CVRx, Inc. is the larger business by last-quarter revenue ($16.0M vs $9.1M, roughly 1.8× PURE CYCLE CORP). PURE CYCLE CORP runs the higher net margin — 50.0% vs -74.5%, a 124.4% gap on every dollar of revenue. On growth, PURE CYCLE CORP posted the faster year-over-year revenue change (58.8% vs 4.4%). Over the past eight quarters, PURE CYCLE CORP's revenue compounded faster (69.0% CAGR vs 22.0%).

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

Pure Cycles, is a bicycle company based in Los Angeles, California that was founded by Michael Fishman, Jordan Schau, Zachary Schau and Austin Stoffers in 2010, as Pure Fix Cycles.

CVRX vs PCYO — Head-to-Head

Bigger by revenue
CVRX
CVRX
1.8× larger
CVRX
$16.0M
$9.1M
PCYO
Growing faster (revenue YoY)
PCYO
PCYO
+54.4% gap
PCYO
58.8%
4.4%
CVRX
Higher net margin
PCYO
PCYO
124.4% more per $
PCYO
50.0%
-74.5%
CVRX
Faster 2-yr revenue CAGR
PCYO
PCYO
Annualised
PCYO
69.0%
22.0%
CVRX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CVRX
CVRX
PCYO
PCYO
Revenue
$16.0M
$9.1M
Net Profit
$-11.9M
$4.6M
Gross Margin
86.3%
68.4%
Operating Margin
-69.8%
48.0%
Net Margin
-74.5%
50.0%
Revenue YoY
4.4%
58.8%
Net Profit YoY
-12.0%
16.0%
EPS (diluted)
$-0.45
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
PCYO
PCYO
Q4 25
$16.0M
$9.1M
Q3 25
$14.7M
$11.2M
Q2 25
$13.6M
$5.1M
Q1 25
$12.3M
$4.0M
Q4 24
$15.3M
$5.8M
Q3 24
$13.4M
$12.6M
Q2 24
$11.8M
$7.6M
Q1 24
$10.8M
$3.2M
Net Profit
CVRX
CVRX
PCYO
PCYO
Q4 25
$-11.9M
$4.6M
Q3 25
$-12.9M
$6.1M
Q2 25
$-14.7M
$2.3M
Q1 25
$-13.8M
$809.0K
Q4 24
$-10.7M
$3.9M
Q3 24
$-13.1M
$6.6M
Q2 24
$-14.0M
$2.8M
Q1 24
$-22.2M
$118.0K
Gross Margin
CVRX
CVRX
PCYO
PCYO
Q4 25
86.3%
68.4%
Q3 25
86.8%
67.7%
Q2 25
84.3%
63.4%
Q1 25
83.5%
38.2%
Q4 24
83.2%
63.8%
Q3 24
83.2%
77.8%
Q2 24
83.9%
64.0%
Q1 24
85.0%
55.6%
Operating Margin
CVRX
CVRX
PCYO
PCYO
Q4 25
-69.8%
48.0%
Q3 25
-83.5%
53.1%
Q2 25
-105.8%
26.0%
Q1 25
-108.8%
-33.2%
Q4 24
-67.0%
29.9%
Q3 24
-97.3%
62.0%
Q2 24
-118.3%
40.3%
Q1 24
-206.4%
-11.5%
Net Margin
CVRX
CVRX
PCYO
PCYO
Q4 25
-74.5%
50.0%
Q3 25
-87.6%
54.5%
Q2 25
-108.4%
43.9%
Q1 25
-111.5%
20.3%
Q4 24
-69.4%
68.4%
Q3 24
-98.0%
52.6%
Q2 24
-118.8%
37.2%
Q1 24
-206.0%
3.7%
EPS (diluted)
CVRX
CVRX
PCYO
PCYO
Q4 25
$-0.45
$0.19
Q3 25
$-0.49
$0.26
Q2 25
$-0.57
$0.09
Q1 25
$-0.53
$0.03
Q4 24
$-0.39
$0.16
Q3 24
$-0.57
$0.27
Q2 24
$-0.65
$0.12
Q1 24
$-1.04
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
PCYO
PCYO
Cash + ST InvestmentsLiquidity on hand
$75.7M
$17.1M
Total DebtLower is stronger
$8.0M
Stockholders' EquityBook value
$39.3M
$147.5M
Total Assets
$104.8M
$168.1M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
PCYO
PCYO
Q4 25
$75.7M
$17.1M
Q3 25
$85.1M
$21.9M
Q2 25
$95.0M
$14.4M
Q1 25
$102.7M
$16.5M
Q4 24
$105.9M
$19.0M
Q3 24
$100.2M
$22.1M
Q2 24
$70.4M
$20.5M
Q1 24
$80.1M
$20.6M
Total Debt
CVRX
CVRX
PCYO
PCYO
Q4 25
$8.0M
Q3 25
$6.8M
Q2 25
$6.9M
Q1 25
$6.9M
Q4 24
$6.9M
Q3 24
$6.9M
Q2 24
Q1 24
Stockholders' Equity
CVRX
CVRX
PCYO
PCYO
Q4 25
$39.3M
$147.5M
Q3 25
$48.1M
$142.7M
Q2 25
$57.9M
$136.7M
Q1 25
$71.1M
$134.4M
Q4 24
$71.1M
$133.6M
Q3 24
$65.2M
$129.7M
Q2 24
$55.2M
$123.2M
Q1 24
$66.3M
$120.4M
Total Assets
CVRX
CVRX
PCYO
PCYO
Q4 25
$104.8M
$168.1M
Q3 25
$111.3M
$162.3M
Q2 25
$119.6M
$151.7M
Q1 25
$129.6M
$149.7M
Q4 24
$133.4M
$149.7M
Q3 24
$127.7M
$147.4M
Q2 24
$96.0M
$140.4M
Q1 24
$106.2M
$135.2M
Debt / Equity
CVRX
CVRX
PCYO
PCYO
Q4 25
0.05×
Q3 25
0.05×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
PCYO
PCYO
Operating Cash FlowLast quarter
$-9.8M
$-979.0K
Free Cash FlowOCF − Capex
$-9.8M
FCF MarginFCF / Revenue
-61.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
-0.21×
TTM Free Cash FlowTrailing 4 quarters
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
PCYO
PCYO
Q4 25
$-9.8M
$-979.0K
Q3 25
$-9.7M
$9.4M
Q2 25
$-7.9M
$-503.0K
Q1 25
$-12.8M
$-1.4M
Q4 24
$-8.0M
$5.7M
Q3 24
$-10.4M
$3.1M
Q2 24
$-9.8M
$892.0K
Q1 24
$-10.9M
$-457.0K
Free Cash Flow
CVRX
CVRX
PCYO
PCYO
Q4 25
$-9.8M
Q3 25
$-10.0M
Q2 25
$-8.0M
Q1 25
$-12.9M
Q4 24
$-8.1M
Q3 24
$-10.4M
Q2 24
$-10.2M
Q1 24
$-11.8M
FCF Margin
CVRX
CVRX
PCYO
PCYO
Q4 25
-61.3%
Q3 25
-68.1%
Q2 25
-59.2%
Q1 25
-104.3%
Q4 24
-52.5%
Q3 24
-78.1%
Q2 24
-86.3%
Q1 24
-109.7%
Capex Intensity
CVRX
CVRX
PCYO
PCYO
Q4 25
0.4%
Q3 25
2.0%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
3.0%
Q1 24
8.5%
Cash Conversion
CVRX
CVRX
PCYO
PCYO
Q4 25
-0.21×
Q3 25
1.53×
Q2 25
-0.22×
Q1 25
-1.70×
Q4 24
1.44×
Q3 24
0.47×
Q2 24
0.32×
Q1 24
-3.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

PCYO
PCYO

Construction$6.5M71%
Water And Wastewater Resource Development Segment$2.5M27%

Related Comparisons